The grant will help deliver reliable vaccine information to help Canadians make evidence-based decisions on vaccines.
Category: Community
GlycoNet start-up listed as top 10 therapeutics start-ups and companies in Edmonton
48Hour Discovery shows exceptional innovation, growth, management, and societal impact, according to BestStartup.
GlycoNet Investigator meets the Parliamentary Health Research Caucus to present glycomics research
Dr. Yves St-Pierre shared how glycomics could help develop a new-generation cancer immunotherapy.
GlycoNet Investigator featured in “100 Lives of Insulin” project
Dr. Mike Riddell has spent his career looking at ways to make diabetes easier and safer for those who are living with it. He talks about the why and how behind it.
Canadian company blazes a new trail to drug development
A prime example of Canada’s success in the sub‑sector of the life sciences industry is 48Hour Discovery
GlycoNet joins BioTalent Canada’s partnership network
Partnership will improve the career prospects in the biotechnology and life sciences sectors in Canada
Carbohydrate classroom reaches Northwest Territories and Northern British Columbia
High school teachers become students for one day to learn about glycoscience
GlycoNet launches equity, diversity, and inclusion program to achieve a more diverse and productive research community
The training program will equip participants with knowledge about EDI fundamentals and unconscious bias.
GlycoNet Investigator named to the Order of Canada
Dr. Lori West receives one of Canada’s highest honours to recognize her leadership in organ transplantation and donation.
Top 10 stories from GlycoNet in 2020
A year in review in glycomics innovations.
English 
French